Involvement of microRNA in Asthma: New perspective in respiratory biology
Indian Journal of Allergy, Asthma and Immunology · 2013
DOI: 10.4103/0972-6691.116603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Allergy, Asthma and Immunology, 2013. Verfasst von Balaram Ghosh. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
A new insights have come from studies in Caenorhabditis elegans, in which researchers have identified a new endogenous class of small noncoding RNA (22-25 nucleotides), termed as microRNAs (miRNAs) as developmental regulators. Here, we discuss some recent studies demonstrating the role of miRNAs in asthma, with the anticipation that these studies were likely to influence treatment, diagnosis, and management of asthma and other inflammatory disorders. use of miRNAs as a therapy, the use of miRNAs holds great promise as a new treatment. Future of miRNA-based therapy in case of pulmonary disorders, such as asthma, chronic obstructive pulmonary disease (COPD), acute lung injury (ALI), and acute respiratory distress syndrome (ARDS) seems to be promising as indicated by animal studies.
Zitieren
APA
Ghosh, B. (2013). Involvement of microRNA in Asthma: New perspective in respiratory biology. Indian Journal of Allergy, Asthma and Immunology. https://doi.org/10.4103/0972-6691.116603
Vancouver
Ghosh B. Involvement of microRNA in Asthma: New perspective in respiratory biology. Indian Journal of Allergy, Asthma and Immunology. 2013. doi:10.4103/0972-6691.116603
BibTeX
@article{Ghosh2013,
author = {Ghosh, Balaram},
title = {Involvement of microRNA in Asthma: New perspective in respiratory biology},
journal = {Indian Journal of Allergy, Asthma and Immunology},
year = {2013},
doi = {10.4103/0972-6691.116603}
}
EUVIMED